APA (7th ed.) Citation

Sabbagh, M. N., Zhao, C., Mahendran, M., Jang, S. R., Laliberté, F., Toyosaki, H., . . . Nair, K. V. (2025). Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States. Neurology and Therapy, 14(3), 1115. https://doi.org/10.1007/s40120-025-00756-4

Chicago Style (17th ed.) Citation

Sabbagh, Marwan N., Chenyue Zhao, Malena Mahendran, Se Ryeong Jang, François Laliberté, Hideki Toyosaki, Kaixin Zhang, Feride Frech, and Kavita V. Nair. "Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States." Neurology and Therapy 14, no. 3 (2025): 1115. https://doi.org/10.1007/s40120-025-00756-4.

MLA (9th ed.) Citation

Sabbagh, Marwan N., et al. "Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States." Neurology and Therapy, vol. 14, no. 3, 2025, p. 1115, https://doi.org/10.1007/s40120-025-00756-4.